Hornet Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Hornet Therapeutics's estimated annual revenue is currently $775k per year.
- Hornet Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Hornet Therapeutics has 5 Employees.
- Hornet Therapeutics grew their employee count by 0% last year.
Hornet Therapeutics's People
Name | Title | Email/Phone |
---|
Hornet Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Hornet Therapeutics?
Hornet Therapeutics is a biotech company focused on developing treatments to address Epstein-Barr Virus (EBV) driven pathologies. The Company was founded by 4BIO Capital and Professor Christoph Hess, based on breakthrough work from Christoph Hess’s lab on translational aspects of lymphocyte function and its metabolic basis. Whilst in incubation, the Company established pioneering single gene-level precision engineering of immune cell metabolism to induce or abolish specific cellular states.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 5 | -29% | $36M |
#2 | $0.6M | 5 | -29% | N/A |
#3 | $0.1M | 5 | -29% | $12M |
#4 | $0.5M | 5 | -17% | $76.7M |
#5 | $0.4M | 5 | 0% | N/A |